why choose us

300×250 Ad Slot

Research Article: A novel NLRP3 inhibitor as a therapeutic agent against monosodium urate-induced gout

Date Published: 2024-02-27

Abstract:
Background: Since NEK7 is critical for NLRP3 inflammasome activation, NEK7 inhibitors could be employed as therapeutic agents against gout, a representative disease caused by NLRP3 inflammasome.

No summary available.

300×250 Ad Slot